Breathalyzer market projections:
According to WinterGreen Research, Breathalyzer markets at $284.6 million in 2011 are anticipated to reach $3.2 billion in 2018. Market growth comes in large part from development of a new market for breath analysis as a healthcare diagnostic tool.
Zion Market Research has published a new report titled “Breath Analyzers (Fuel Cell, Semiconductor, Infrared and Crystal)
According to the report, global demand for breath analyzer market was valued at USD 500.0 million in 2015 and is expected to reach USD 1,600.0 million in 2021, growing at a CAGR of 25% between 2016 and 2021.
According to a report by Mordor Intelligence, the global breathalyzer market has been estimated to be worth USD $3 billion for the year 2018 and is projected to hit USD 10 billion by 2021, at a CAGR of 25% during the forecast period 2016-2021. The market is set to be driven mostly by the fuel cell technology (This is what LCTC uses)
Keep in mind, when Lifeloc is ready to go with it's marijuana breathalyzer, it will have the advantage of already being positioned with manufacturing and distribution networks in the well-established alcohol breathalyzer market.
Currently the market cap for Lifeloc stands at a mere $17.3 million. If Lifeloc can capture just 1% of the total alcohol and marijuana breathalyzer market by 2018 (let's just say each market is worth $2 billion), then I'd expect an increase in market cap to $40 million or a stock price of at least $16/share. Things get interesting when LCTC begins to capture lets say 2.5% of a projected $10 billion market. That would be worth $250 million and would put the price of LCTC stock right around $100. Keep in mind these are very conservative numbers and there are only a handful of companies working on the marijuana breathalyzer. Imagine what could happen if they are able to capture 5, 10, or even 25% of that total market and continue to have a trading float of less than 200,000 shares?
Oh man!!!
